{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:52:23Z","timestamp":1780667543130,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.rmed.2024.107817","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T21:33:07Z","timestamp":1727127187000},"page":"107817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Prevalence and significance of pulmonary hypertension among hospitalized patients with left heart disease"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0586-6386","authenticated-orcid":false,"given":"Ioannis T.","family":"Farmakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hobohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4466-0724","authenticated-orcid":false,"given":"Luca","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Helge","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph Stephan","family":"von Bardeleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Lurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Rosenkranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros V.","family":"Konstantinides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-6319","authenticated-orcid":false,"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2024.107817_bib1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/eurheartj\/ehv512","article-title":"Left ventricular heart failure and pulmonary hypertension","volume":"37","author":"Rosenkranz","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2024.107817_bib2","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/ehf2.13386","article-title":"Predictors and prognosis of right ventricular function in pulmonary hypertension due to heart failure with reduced ejection fraction","volume":"8","author":"Schmeisser","year":"2021","journal-title":"ESC heart failure"},{"key":"10.1016\/j.rmed.2024.107817_bib3","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.jacc.2022.08.757","article-title":"Impact of periprocedural pulmonary hypertension on outcomes after transcatheter aortic valve replacement","volume":"80","author":"Miyamoto","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2024.107817_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/jamacardio.2018.0128","article-title":"Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction","volume":"3","author":"Vanderpool","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.rmed.2024.107817_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehac237","article-title":"ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Humbert","year":"2022","journal-title":"European Heart Journal 2022"},{"key":"10.1016\/j.rmed.2024.107817_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcad.2016.07.001","article-title":"Epidemiology of pulmonary hypertension in left heart disease","volume":"59","author":"Guha","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.rmed.2024.107817_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2024.107817_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jchf.2013.05.001","article-title":"Clinical features, hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: pulmonary hypertension and heart failure","volume":"1","author":"Miller","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.rmed.2024.107817_bib9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00078411","article-title":"ASPIRE registry: assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre","volume":"39","author":"Hurdman","year":"2012","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107817_bib10","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.healun.2014.04.014","article-title":"Pulmonary hypertension related to left heart disease: insight from a wireless implantable hemodynamic monitor","volume":"34","author":"Benza","year":"2015","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.rmed.2024.107817_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jcmg.2018.02.015","article-title":"Pulmonary hypertension in patients with severe aortic stenosis: prognostic impact after transcatheter aortic valve replacement: pulmonary hypertension in patients undergoing TAVR","volume":"12","author":"Alushi","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.rmed.2024.107817_bib12","volume":"8","author":"O'Sullivan","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.rmed.2024.107817_bib13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jtcvs.2011.08.030","article-title":"Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery","volume":"142","author":"Ghoreishi","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.rmed.2024.107817_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018394","article-title":"Increased mortality in patients with preoperative and persistent postoperative pulmonary hypertension undergoing mitral valve surgery for mitral regurgitation: a cohort study","volume":"10","author":"Genuardi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.rmed.2024.107817_bib15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/heartjnl-2022-322184","article-title":"Prevalence of pulmonary hypertension in aortic stenosis and its influence on outcomes","volume":"109","author":"Ratwatte","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.rmed.2024.107817_bib16","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1136\/heartjnl-2022-322187","article-title":"Prevalence of pulmonary hypertension in aortic regurgitation and its influence on outcomes","volume":"109","author":"Ratwatte","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.rmed.2024.107817_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2023-002268","article-title":"Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes","volume":"10","author":"Ratwatte","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.rmed.2024.107817_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/heartjnl-2022-321565","article-title":"Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction","volume":"109","author":"Sera","year":"2023","journal-title":"Heart"},{"key":"10.1016\/j.rmed.2024.107817_bib19","article-title":"The prevalence and survival of pulmonary hypertension due to left heart failure: a retrospective analysis of a multicenter prospective cohort study","volume":"9","author":"Lin","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.rmed.2024.107817_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jacc.2008.11.051","article-title":"Pulmonary hypertension in heart failure with preserved ejection fraction","volume":"53","author":"Lam","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2024.107817_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2011.06.076","article-title":"Pulmonary pressures and death in heart failure","volume":"59","author":"Bursi","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2024.107817_bib22","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2016.09.942","article-title":"Clinical and biological insights into combined post- and pre-capillary pulmonary hypertension","volume":"68","author":"Assad","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.rmed.2024.107817_bib23","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1164\/rccm.201503-0529OC","article-title":"Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival","volume":"192","author":"Gerges","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107817_bib24","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1093\/eurheartj\/ehac184","article-title":"Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications","volume":"43","author":"Omote","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2024.107817_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2024.107817_bib26","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","article-title":"Isosorbide mononitrate in heart failure with preserved ejection fraction","volume":"373","author":"Redfield","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2024.107817_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.rmed.2024.107817_bib28","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/ejhf.2527","article-title":"Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo\u2010controlled multicentre trial","volume":"24","author":"Cooper","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.rmed.2024.107817_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024449","article-title":"Effect of sacubitril\/valsartan on the right ventricular function and pulmonary hypertension in patients with heart failure with reduced ejection fraction: a systematic review and meta\u2010analysis of observational studies","volume":"11","author":"Zhang","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.rmed.2024.107817_bib30","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/echo.14813","article-title":"Impact of \u03b2\u2010blocker therapy on right ventricular function in heart failure patients with reduced ejection fraction. A prospective evaluation","volume":"37","author":"Galves","year":"2020","journal-title":"Echocardiography"},{"key":"10.1016\/j.rmed.2024.107817_bib31","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.119.313572","article-title":"Heart failure with preserved ejection fraction in perspective","volume":"124","author":"Pfeffer","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.rmed.2024.107817_bib32","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jcin.2019.08.031","article-title":"Impact of pulmonary hypertension hemodynamic status on long-term outcome after transcatheter aortic valve replacement","volume":"12","author":"Schewel","year":"2019","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.rmed.2024.107817_bib33","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.carrev.2018.03.015","article-title":"The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: a systematic review and meta-analysis","volume":"19","author":"Kokkinidis","year":"2018","journal-title":"Cardiovasc. Revascularization Med."},{"key":"10.1016\/j.rmed.2024.107817_bib34","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.jacc.2020.09.609","article-title":"Pulmonary hypertension in transcatheter mitral valve repair for secondary mitral regurgitation: the COAPT trial","volume":"76","author":"Ben-Yehuda","year":"2020","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124002920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124002920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T22:33:16Z","timestamp":1732314796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124002920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":34,"alternative-id":["S0954611124002920"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107817","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and significance of pulmonary hypertension among hospitalized patients with left heart disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107817"}}